<code id='CD9166DBBE'></code><style id='CD9166DBBE'></style>
    • <acronym id='CD9166DBBE'></acronym>
      <center id='CD9166DBBE'><center id='CD9166DBBE'><tfoot id='CD9166DBBE'></tfoot></center><abbr id='CD9166DBBE'><dir id='CD9166DBBE'><tfoot id='CD9166DBBE'></tfoot><noframes id='CD9166DBBE'>

    • <optgroup id='CD9166DBBE'><strike id='CD9166DBBE'><sup id='CD9166DBBE'></sup></strike><code id='CD9166DBBE'></code></optgroup>
        1. <b id='CD9166DBBE'><label id='CD9166DBBE'><select id='CD9166DBBE'><dt id='CD9166DBBE'><span id='CD9166DBBE'></span></dt></select></label></b><u id='CD9166DBBE'></u>
          <i id='CD9166DBBE'><strike id='CD9166DBBE'><tt id='CD9166DBBE'><pre id='CD9166DBBE'></pre></tt></strike></i>

          explore

          explore

          author:knowledge    Page View:13
          This image provided by Novo Nordisk in January 2023, shows packaging for the company's Wegovy drug.
          Novo Nordisk via AP

          PHILADELPHIA — Novo Nordisk’s obesity drug Wegovy notably cut the risk of heart attacks in a landmark cardiovascular trial that affirms the treatment offers health benefits beyond weight loss.

          The company in August had announced that in this trial, called Select, Wegovy reduced the overall rate of major heart problems — heart attacks, stroke, or cardiovascular-related death — by 20%. That finding, which was the primary outcome the trial set out to study, was stronger than many were expecting and led Novo’s stock to surge.

          advertisement

          But details of the study, including risk reductions for each specific heart complication, were not released until Saturday, when they were presented here — before a standing-room only crowd — as the first major session of the American Heart Association conference. 

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          The Supreme Court will review a ruling striking down a domestic violence federal gun ban
          The Supreme Court will review a ruling striking down a domestic violence federal gun ban

          WASHINGTON--TheSupremeCourtwillreviewarulingstrikingdownadomesticviolencefederalgunban.

          read more
          Biden's Plan B on student loan forgiveness relies on Higher Education Act: What to know
          Biden's Plan B on student loan forgiveness relies on Higher Education Act: What to know

          2:59PresidentJoeBidenspeaksabouthisplansforcontinuedstudentdebtreliefafteraU.S.SupremeCourtdecisionb

          read more
          Medical leaders decry Supreme Court decision on affirmative action
          Medical leaders decry Supreme Court decision on affirmative action

          STEFANIREYNOLDS/AFPviaGettyImagesMedicalleadersonThursdayreactedswiftlytotheSupremeCourt’sdecisionto

          read more

          Readout Newsletter: Parkinson's study, Gilead, CG Oncology

          AdobeWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechnewsletterinyo